Northwest Biotherapeutics (NWBO) Reports Q3 Loss of $0.35/Share
Tweet
Share
E-mailGet Alerts NWBO Hot Sheet
Price: $0.17 --0%
Financial Fact:
Loan conversion inducement: -1.46M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
Loan conversion inducement: -1.46M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Northwest Biotherapeutics (NASDAQ: NWBO) reported Q3 EPS of ($0.35), versus ($0.65) reported last year. Revenue for the quarter came in at $582 thousand, versus $400 thousand reported last year.
For earnings history and earnings-related data on Northwest Biotherapeutics (NWBO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SailPoint Technologies Holdings (SAIL) PT Raised to $25 by Cantor Fitzgerald on Solid Checks
- GE Vernova T&D India (GVTD:IN) PT Raised to INR5,300 at Emkay Global
- Getty Realty (GTY) Reiterated at Market Outperform by Citizens Amid Favourable Trends
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
